# A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids.

> **NCT00156182** · PHASE2 · COMPLETED · sponsor: **Abbott** · enrollment: 38 (actual)

## Conditions studied

- Leiomyoma

## Interventions

- **DRUG:** Asoprisnil

## Key facts

- **NCT ID:** NCT00156182
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-04
- **Primary completion:** 2001-12
- **Final completion:** 2001-12
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2009-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00156182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00156182, "A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids.". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00156182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*